Adems, su capacidad para mejorar la secrecin de insulina y reducir la glucosa posprandial lo convierte en un agente teraputico importante en el manejo de la diabetes tipo 2
For a 2.5 mg dose at 5 mg/mL concentration, draw to the 50-unit line
McCarty D, Olenik A, McCarty BP (2019) Efficacy and safety of basal insulin/GLP-1 receptor agonist used in combination for type 2 diabetes management
Snack Foods See the Biggest Drop The sharpest declines appeared in ultra-processed, high-calorie foods that are often linked to cravings
Already large, already growing, with the clearest staying power
While less effective, they provide a baseline option that is always accessible regardless of insurance decisions, pharmacy stock levels, or regulatory changes